YR1307
科研级 Idarucizumab ( 艾达赛珠单抗 ), Anti-Dabigatran Etexilate Mesylate Recombinant Antibody, Research Grade Idarucizumab
| Alias | 科研级 Idarucizumab ( 艾达赛珠单抗 ), Anti-Dabigatran Etexilate Mesylate Recombinant Antibody, Research Grade Idarucizumab |
| Catalog Number | YR1307 |
| Molecular Name | Idarucizumab |
| Host | Mouse |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | Fab |
| Formulation | PBS, pH7.5 |
| Background | Idarucizumab, sold under the brand name Praxbind, is a monoclonal antibody used as a reversal agent for dabigatran. Idarucizumab was developed by Boehringer Ingelheim. One study sponsored by the manufacturer found that idarucizumab effectively reversed anticoagulation caused by dabigatran within minutes. |
| CAS Number | 1362509-93-0 |
| Application | IP, IF, FuncS, FCM, Neut, ELISA, IHC, PK, Activ |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | dabigatran etexilate mesylate[Drug] |
Service Account
0
